MIB Agents Osteosarcoma Alliance

AIRING TODAY! "The Sibling Situation" Christopher Kuo osTEAo: The Osteosarcoma Podcast, is a podcast dedicated to demystifying life with cancer and illness, from the perspective of AYA patients. Panelists consist of patients, siblings, and caregivers affected by Osteosarcoma who are occasionally joined with healthcare experts to talk all things AYA cancer. WATCH HERE: https://lnkd.in/gC6UMeuT #osteosarcoma #ayacancer #ayacancerpodcast #osteosarcomapodcast #osTEAo #spillingthetea

Thursday, we were joined by Olivier Elemento, PhD, on OsteoBites to discuss, "Genomes, Avatars and AI: The Future of Personalized Medicine" Watch the full episode here: https://lnkd.in/g-jEAbyQ Olivier Elemento, PhD, is a professor of physiology and biophysics at Weill Cornell Medicine. Since 2017, he has been the Director of the Caryl and Israel Englander Institute for Precision Medicine, a large multi-disciplinary institute that uses precision medicine technologies and informatics to uncover the molecular mechanisms of disease and individualize disease treatment and prevention. He is also the Associate Director of the Institute for Computational Medicine, Director of the Laboratory of Cancer Systems Biology, Co-Leader of the Genetics, Epigenetics, and Systems Biology Program in the Meyer Cancer Center at Weill Cornell Medicine. His research group combines Big Data, Artificial Intelligence with experimentation and genomic profiling to accelerate the discovery of cancer cures. #MIBAgents #MakeItBetter #osteosarcoma #OsteoBites #podcast

Day 3 F24! Our last day of FACTOR 2024 in Cleveland was a success! We are so thankful for everyone who showed up, supported us, and put in the work and effort to start Making It Better! We are truly grateful for this community and those who continue to support us in many ways. This is all possible because of YOU! Remember to tag us in your #FACTOR2024 memories! We already cannot wait until next year! #MIBAgents #MakeItBetter #osteosarcoma #FACTOR2024 #YouBelongHere

We are thrilled to announce our OutSmarting Osteosarcoma 2024 research grant recipients! They are Making It Better with us by studying new therapies for osteosarcoma. Two $100K grant recipients: Shahana S. Mahajan, PhD | Hunter College of the City University of New York Jill Kolesar, PharmD | University of Kentucky Markey Cancer Center Three $50K grant recipients (that are cobranded with FFs/Because Ofs) Betsy Young, MD | University of California, San Francisco - Because of Charlotte Chelsey Burke, MD | Memorial Sloan Kettering Cancer Center - Because of Ava Arianexys Aquino-López, MD, PhD | Baylor College of Medicine - Because of Sydney Thank you for Making It Better! #MIBAgents #MakeItBetter #osteosarcoma #OutSmartingOsteosarcoma

OSI Connect is a free, easy-to-use resource dedicated to supporting osteosarcoma patients and their families. It connects those affected by the devastating disease with expert physicians to answer questions about all aspects of osteosarcoma, including treatment, possible side effects, and advice for getting the most out of patient visits with their treating physician. Dr. Helman is going to be available for a very limited number of one-on-one consultations at FACTOR 2024. Please use the OSI Connect email (Connect@osinst.org) for more information or go directly to the OSI Connect page on our website (https://lnkd.in/daZPWK-E) if you will not be attending F24. We can't wait to see you there! #MIBAgents #MakeItBetter #osteosarcoma #OSIConnect #FACTOR2024 #YouBelongHere The Osteosarcoma Institute

Yesterday we were joined by José Granados Soler, DVM, MSc, PhD and Rachel Allavena, PhD on OsteoBites to discuss, "Exploring Novel Immunotherapies for Canine Osteosarcoma" Watch the full episode here: https://lnkd.in/gY2mPPYc Dr. José Granados Soler, DVM, MSc, PhD, a graduate of the National University of Colombia, initially pursued small animal surgery before transitioning into roles as an educator and researcher. His academic journey led him to Spain and Germany, where he focused on feline and canine mammary cancer research during his master's and doctoral studies. Now based in Australia at the University of Queensland, Dr. Granados Soler serves as a small animal surgeon, educator, and researcher, collaborating with Prof. Allavena on pioneering immunotherapeutic trials for osteosarcoma and other cancers in dogs. He remains dedicated to making impactful contributions to the field, with a steadfast commitment to continuous learning and improvement. Prof Rachel Allavena is the Deputy Head of the School of Veterinary Science, The University of Queensland. She teaches toxicology, pathology, animal welfare and laboratory animal science to science and veterinary students. Prof Allavena is a specialist veterinary anatomic pathologist and is board certified by the American College of Veterinary Pathologists. Her research interest focuses on translational and comparative medicine. Principally on pet dogs with natural cancer as a translational model for oncology research, on which she presented at TEDx talk. Her canine trials have focused on bone cancer, melanoma, lymphoma and mastocytoma. Her research includes biomedical device development, koala conservation, racing animal welfare and production animal disease and economics. Since commencing her academic career in 2011 she has received AUD $13.7 million of grant and contract funding for research, published over 60 peer reviewed journal articles and won several teaching awards, including UQ’s Citation for Outstanding Contribution to Student Learning in 2021. #MIBAgents #MakeItBetter #osteosarcoma #OsteoBites #podcast

Thursday, we were joined by Matteo Trucco, MD, on OsteoBites to discuss, "A Guide to the FACTOR 2024 Scientific Panels". Watch the full episode here: https://lnkd.in/gmimtPHs Matteo Trucco is a Pediatric Oncologist and the Clinical Director of Pediatric Hematology/Oncology at Cleveland Clinic Children’s, specializing in the care of children, teenagers and young adults battling bone and soft tissue cancers. He also directs the Children’s Cancer Innovative Therapy Program where he and colleagues design, develop and conduct clinical trials seeking more effective and less toxic treatments for childhood cancers. Dr. Trucco earned his undergraduate degree from the University of Pennsylvania and Medical Degree from Temple University School of Medicine. He completed his Pediatrics Residency at Rainbow Babies and Children’s Hospital and his Pediatric Hematology/Oncology Fellowship from Johns Hopkins and the National Cancer Institute. In addition to his roles at the Cleveland Clinic, he is a Co-chair of the National Pediatric Cancer Foundation’s Sunshine Project consortium, partnering with other top pediatric cancer centers to develop clinical trials. He is honored to be on the Board of MIB Agents, chairs its Scientific Advisory Committee and co-chairs the organizing committee for the FACTOR Conference. He also has the privilege of moderating MIB Agents’ TURBO Tumor Board. #MIBAgents #MakeItBetter #osteosarcoma #OsteoBites #podcast

Yesterday, we were joined by Amy LeBlanc, DVM on OsteoBites to discuss, "Creating a translational genomic framework for canine osteosarcoma: updates on the NCI DOG2 project". Watch the full episode here: https://lnkd.in/gJSwtEes Dr. Amy LeBlanc is a board-certified veterinary oncologist, Senior Scientist and Director of the CCR Comparative Oncology Program at the National Cancer Institute, NIH. In this position, she directly oversees and manages the operations of the Comparative Oncology Trials Consortium (COTC), which designs and executes clinical trials of new cancer therapies in tumor-bearing pet dogs. She will be joining us on OsteoBites to discuss findings as we work toward genomic and transcriptional profiling of canine osteosarcoma and how the results relate to human osteosarcoma. The DOG2 project was launched to better understand the relationships between the disease in dogs and humans -- all to make it better for all patients, be they 2-legged or 4 legged! #MIBAgents #MakeItBetter #osteosarcoma #OsteoBites #podcast

FACTOR Scientific Panel Highlight #10! "Clinical Trials" Learn more about FACTOR https://lnkd.in/gm53JTiD and remember to sign up for FACTOR 2024 CLEVELAND! https://lnkd.in/gFWTQ7nU... #MIBAgents #MakeItBetter #osteosarcoma #YouBelongHere #FACTOR2024

FACTOR Scientific Panel Highlight #9! "Immunotherapy Approaches" Learn more about FACTOR https://lnkd.in/gm53JTiD and remember to sign up for FACTOR 2024 CLEVELAND! https://lnkd.in/gFWTQ7nU... #MIBAgents #MakeItBetter #osteosarcoma #YouBelongHere #FACTOR2024